🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

9 results for “Wyeth is now a wholly owned subsidiary of Pfizer” Clear

  1. DVS SR

    Wyeth is now a wholly owned subsidiary of Pfizer

    Depressive Disorder, Major

    phase 3 small molecule completed

    1 trial

  2. tigecycline

    Wyeth is now a wholly owned subsidiary of Pfizer

    Community-Acquired Infections

    phase 3 small molecule completed

    1 trial

  3. Double-blind investigational anti-arrhythmic

    Wyeth is now a wholly owned subsidiary of Pfizer

    Arrhythmias

    phase 2 small molecule terminated

    1 trial

  4. SAM-315

    Wyeth is now a wholly owned subsidiary of Pfizer

    Alzheimer Disease

    phase 1 small molecule completed

    1 trial

  5. Etanercept , Methotrexate

    Wyeth is now a wholly owned subsidiary of Pfizer

    Rheumatoid Arthritis

    approved small molecule completed

    1 trial

  6. ReFacto

    Wyeth is now a wholly owned subsidiary of Pfizer

    Hemophilia A

    approved small molecule terminated

    1 trial

  7. Tigecycline

    Wyeth is now a wholly owned subsidiary of Pfizer

    Skin Diseases, Bacterial

    approved small molecule completed

    1 trial

  8. cyclosporine or tacrolimus

    Wyeth is now a wholly owned subsidiary of Pfizer

    Graft Rejection

    approved small molecule completed

    1 trial

  9. tigecycline

    Wyeth is now a wholly owned subsidiary of Pfizer

    Appendicitis

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources